CHRFAM7A Peptide

D-10, CHRNA7, CHRNA7-DR1, CHRNA7-FAM7A fusion protein,

CHRFAM7A Peptide is used for blocking the activity of CHRFAM7A antibody (catalog number 42-036). The CHRFAM7A antibody ships at 0.5 mg/mL and the CHRFAM7A Peptide ships as a 100 ug pellet. When peptide is reconstituted in 200 uL water, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.

CHRFAM7A peptide is supplied as 100 μg of dried peptide. When the peptide is reconstituted in 200 μL water, the concentration will be 0.5 mg/mL.

89832

CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion

CHRFAM7A

Homo sapiens

CHRFAM7A peptide is a synthetic peptide cooresponding to 12 amino acids from the N Terminus of CHRFAM7A.

Lyophilized

NP_647536.1

23312388

Q494W8